WallStreetZenWallStreetZen

NASDAQ: PLRX
Pliant Therapeutics Inc Stock Ownership - Who owns Pliant Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Pliant Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Eric LefebvreChief Medical Officer2024-01-1710,295$17.23
$177.38kSell
Mike OuimetteGeneral Counsel Corp. Secy2024-01-175,197$17.23
$89.54kSell
Hans HullChief Business Officer2024-01-179,786$17.23
$168.61kSell
Keith Lamont CummingsChief Financial Officer2024-01-179,781$17.23
$168.53kSell
Bernard CouliePresident and CEO2024-01-1725,721$17.23
$443.17kSell
Hans HullChief Business Officer2023-08-0420,050$20.01
$401.20kSell
Hans HullChief Business Officer2023-08-048,791$2.08
$18.29kBuy
Hans HullChief Business Officer2023-08-0313,069$20.00
$261.38kSell
Hans HullChief Business Officer2023-08-031,800$20.00
$36.00kSell
Hans HullChief Business Officer2023-08-031,800$2.08
$3.74kBuy

1 of 2

PLRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLRX insiders and whales buy or sell their stock.

PLRX Shareholders

What type of owners hold Pliant Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Matthew G. Robinson26.68%16,069,177$189.78MInsider
Deep Track Capital LP9.55%5,750,000$67.91MInstitution
Blackrock Inc7.97%4,801,517$56.71MInstitution
Third Rock Ventures Iii LP7.46%4,495,238$53.09MInsider
Fmr LLC6.58%3,963,418$46.81MInstitution
Price T Rowe Associates Inc6.28%3,785,916$44.71MInstitution
First Light Asset Management LLC5.96%3,591,776$42.42MInstitution
Laurion Capital Management LP5.95%3,583,567$42.32MInstitution
Vanguard Group Inc5.09%3,065,869$36.21MInstitution
Blue Owl Capital Holdings LP4.99%3,004,199$35.48MInstitution

1 of 3

PLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLRX70.74%29.26%Net Selling
ELVN46.22%53.78%Net SellingNet Selling
LBPH45.89%0.09%Net Selling
AUPH36.80%3.18%Net SellingNet Selling
ARCT87.10%12.90%Net SellingNet Selling
View Top Biotech Stocks

Pliant Therapeutics Stock Ownership FAQ

Who owns Pliant Therapeutics?

Pliant Therapeutics (NASDAQ: PLRX) is owned by 104.11% institutional shareholders, 43.06% Pliant Therapeutics insiders, and 0.00% retail investors. Matthew G. Robinson is the largest individual Pliant Therapeutics shareholder, owning 16.07M shares representing 26.68% of the company. Matthew G. Robinson's Pliant Therapeutics shares are currently valued at $189.78M.

If you're new to stock investing, here's how to buy Pliant Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.